Higher expressions of C1R and RPL5 both had significant impacts on overall survival for ALL, AML, and RT, whereas high expression of TERT was significant for survival in ALL, AML, and NBL (Table S5). The gene discussed is RPL5; the disease is acute myeloid leukemia.